产品目录
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 20633 | STX-478 | 2883540-92-7 | ≧98.0% |  |
| STX-478 是第二代突变体选择性口服 PI3Ka 小分子变构抑制剂。 | ||||
| 20604 | SEW2871 | 256414-75-2 | 98% Min. |  |
| SEW2871 is a S1P1 agonist (sphingosine-1-phosphate type 1 receptor agonist). SEW2871 | ||||
| 20576 | STX-721 | 2765525-82-2 | ≧98.0% |  |
| STX-721 is a next-generation, orally delivered therapy, designed with potential best- | ||||
| 20549 | STC-15 | 2648257-56-9 | ≧98.0% |  |
| STC-15 is a first-in-class inhibitor of RNA modification and is the first ever RNA me | ||||
| 20541 | (S)-1-BOC-2-甲基-[1,4]二氮杂环庚烷 | 194032-32-1 | 98% Min. | -1-BOC-2-METHYL-[1,4]DIAZEPANE_194032-32-1.png) |
| 20522 | (S)-5-fluoro-3-methylbenzo[c][1,2]oxaborol-1(3H)-ol | 2921961-53-5 | 98% Min. |  |
| 20516 | (S)-3-氨基-3-(4-氯苯基)-丙酸 | 131690-60-3 | 98% Min. | -3-AMINO-3-(4-CHLORO-PHENYL)-PROPIONIC_ACID_131690-60-3.png) |
| 20454 | Samidorphan | 852626-89-2 | 98% Min. |  |
| Samidorphan, also known as ALKS-33 and RDC-0313, is an opioid modulator with μ-antag | ||||
| 20412 | Spiro[cyclohexane-1,9'(6'H)-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidine]-7'(8'H)-carboxylic acid, 2'-(methylthio)-6'-oxo-5'-[[(trifluoromethyl)sulfonyl]oxy]-, 1,1-dimethylethyl ester | 2170746-98-0 | 98% Min. | -pyrazino[1,2:1,5]pyrrolo[2,3-d]pyrimidine]-7(8H)-carboxylic_acid,_2-(methylthio)-6-oxo-5-[[(trifluoromethyl)sulfonyl]oxy]-,_1,1-dimethylethyl_ester_2170746-98-0.png) |
| 20396 | (S)-1-(6-(4-氟-1H-吡唑-1-甲基)吡啶-3-甲基)乙胺 | 1980023-96-8 | 98% Min. | -1-(6-(4-fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethanamine_1980023-96-8.png) |
| G20378 | SB-4 agonist | 100874-08-6 | 98% Min. |  |
| SB 4 is a potent BMP4 agonist. | ||||
| 822222 | SEP-363856 盐酸盐 | 1310422-41-3 (HCl) | ≧98.0% | .png) |
| SEP-363856 是一种新型微量胺受体 1 (TAAR1) 激动剂，具有血清素 5-HT1 | ||||
| 1711224 | SRI-37330 free base | 2322245-42-9 (free base) | 98% Min. | .jpg) |
| SRI-37330 is a novel inhibitor of TXNIP expression, decreasing glucagon secretion and | ||||
| 20369 | Sunvozertinib ( DZD 9008 ) | 2370013-12-8 | ≧98.0% | _2370013-12-8.png) |
| Sunvozertinib，也称为 DZD9008，是一种口服、强效、不可逆和选择性 | ||||
| 20368 | SHMT-IN-2 抑制剂 | 2102681-49-0 | ≧98.0% |  |
| SHMT-IN-2 是一种丝氨酸羟甲基转移酶 (SHMT) 抑制剂，可有效抑制人 | ||||
| L20355 | SRI-011381 | 1629138-41-5 | 98% Min. |  |
| SRI-011381 is an agonist of the TGF-beta signaling pathway for treatment of Alzheimer | ||||
| L20353 | SJ-172550 | 431979-47-4 | 98% Min. |  |
| SJ-172550, also known as MDMX Inhibitor II, is an inhibitor of MDMX that disrupts MDM | ||||
| 20344 | SMN-C3 抑制剂 | 1449597-34-5 | ≧98.0% |  |
| SMN-C3 是一种口服活性 SMN2 剪接调节剂。可用于脊椎肌肉萎缩 (SMA) | ||||
| L20338 | Stafia-1 | 2582757-90-0 | 98% Min. |  |
| 20321 | STM2457 | 2499663-01-1 | 98% Min. |  |
| STM2457 is a highly potent and selective first-in-class catalytic inhibitor of METTL3 | ||||
| 20306 | SRI-37330 HCl | 2322245-49-6 | ≧98.0% |  |
| SRI-37330 hydrochloride 是一种新型 TXNIP 表达抑制剂，呈剂量依赖性抑 | ||||
| 21252 | SM-102 | 2089251-47-6 | ≧98.0% |  |
| SM-102 is an ionizable amino lipid that has been used in combination with other lipid | ||||
| 21238 | Seralutinib | 1619931-27-9 | 98% Min. |  |
| Seralutinib，也称为 PK-10571 和 GB002，是一种新型吸入性 Pdgfr 激酶抑 | ||||
| 21232 | Sonidegib (LDE-225) | 956697-53-3 | 98% Min. | _956697-53-3.png) |
| Sonidegib, also known as, erismodegib, LDE225, NVP-LDE225, is an orally bioavailable | ||||
| 21230 | SB-366791 | 472981-92-3 | 98% Min. |  |
| SB-366791 is a potent and selective TRPV1 antagonist. SB-366791 inhibits glutamatergi | ||||
| 21229 | Scriptaid | 287383-59-9 | 98% Min. |  |
| Scriptaid, also known as GCK 1026, is a HDAC inhibitor. Scriptaid protects against tr | ||||
| 21228 | SNG-1153 | 1446712-19-1 | 98% Min. |  |
| SNG-1153 is a modulator of estrogen receptor ER-alpha36. | ||||
| 81498 | Seltorexant | 1293281-49-8 | 98% Min. |  |
| Seltorexant, also known as JNJ-42847922 and MIN-202, is a selective orexin-2 receptor | ||||
| 20123103 | (S)-3-(4,6-bis(((R)-1,1,1-trifluoropropan-2-yl)amino)- 1,3,5-triazin-2-yl)-2,6,6-trifluorocyclohex-2-en-1-ol | 2301974-60-5 | 98% Min. | -3-(4,6-bis(((R)-1,1,1-trifluoropropan-2-yl)amino)-_1,3,5-triazin-2-yl)-2,6,6-trifluorocyclohex-2-en-1-ol_2301974-60-5.png) |
| 20123101 | Samelisant | 1415792-84-5 | ≧98.0% |  |
| Samelisantis a novel, highly selective and potent small molecule oral inhibitor targe | ||||